1. Home
  2. MOH vs VTRS Comparison

MOH vs VTRS Comparison

Compare MOH & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOH
  • VTRS
  • Stock Information
  • Founded
  • MOH 1980
  • VTRS 1961
  • Country
  • MOH United States
  • VTRS United States
  • Employees
  • MOH N/A
  • VTRS N/A
  • Industry
  • MOH Medical Specialities
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • MOH Health Care
  • VTRS Health Care
  • Exchange
  • MOH Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • MOH 10.5B
  • VTRS 11.1B
  • IPO Year
  • MOH 2003
  • VTRS N/A
  • Fundamental
  • Price
  • MOH $163.14
  • VTRS $10.30
  • Analyst Decision
  • MOH Hold
  • VTRS Hold
  • Analyst Count
  • MOH 13
  • VTRS 6
  • Target Price
  • MOH $211.17
  • VTRS $11.17
  • AVG Volume (30 Days)
  • MOH 1.6M
  • VTRS 7.0M
  • Earning Date
  • MOH 10-22-2025
  • VTRS 11-06-2025
  • Dividend Yield
  • MOH N/A
  • VTRS 4.64%
  • EPS Growth
  • MOH N/A
  • VTRS N/A
  • EPS
  • MOH 16.24
  • VTRS N/A
  • Revenue
  • MOH $42,842,000,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • MOH $14.48
  • VTRS N/A
  • Revenue Next Year
  • MOH $6.17
  • VTRS $1.61
  • P/E Ratio
  • MOH $9.99
  • VTRS N/A
  • Revenue Growth
  • MOH 14.11
  • VTRS N/A
  • 52 Week Low
  • MOH $151.95
  • VTRS $6.85
  • 52 Week High
  • MOH $359.97
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • MOH 32.69
  • VTRS 57.25
  • Support Level
  • MOH $152.25
  • VTRS $10.18
  • Resistance Level
  • MOH $166.31
  • VTRS $10.50
  • Average True Range (ATR)
  • MOH 5.97
  • VTRS 0.20
  • MACD
  • MOH -4.61
  • VTRS 0.04
  • Stochastic Oscillator
  • MOH 20.72
  • VTRS 73.42

About MOH Molina Healthcare Inc

Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: